Tenegross-20 mg Tablet

Tenegross-20 mg Tablet contains Teneligliptin 20 mg (as Teneligliptin hydrobromide hydrate) tablet. Prescription required.

Type 2 diabetes mellitus (as an adjunct to diet and exercise) to improve glycaemic control; may be used alone or with other antidiabetic medicines as prescribed

Teneligliptin is a DPP-4 inhibitor that increases levels of incretin hormones (GLP-1 and GIP). This enhances glucose-dependent insulin release and reduces glucagon secretion, lowering blood glucose with a low risk of hypoglycaemia when used alone.

Oral tablet. Take as advised by the doctor, usually 20 mg once daily at the same time each day, with or without food. Swallow whole with water; do not stop or change dose without medical advice.

Headache, dizziness, nasopharyngitis/common cold symptoms, constipation, stomach discomfort, nausea, skin rash/itching, hypoglycaemia (more likely when combined with insulin or sulfonylureas)

Not for type 1 diabetes or diabetic ketoacidosis. Use with caution in patients with history of pancreatitis; stop and seek care if severe persistent abdominal pain occurs. Monitor blood glucose regularly; risk of hypoglycaemia increases with sulfonylureas/insulin (dose adjustment may be needed). Use caution in severe liver disease; kidney dose adjustment is generally not required for teneligliptin but follow physician advice. Rare severe hypersensitivity reactions and severe joint pain have been reported with DPP-4 inhibitors.

Insulin and sulfonylureas (increased risk of hypoglycaemia), other antidiabetic medicines (additive glucose-lowering), strong CYP3A4/P-gp inhibitors or inducers may alter teneligliptin levels (clinical relevance variable); inform doctor about all medicines and supplements

Store below 25°C in a cool, dry place. Protect from moisture and direct light. Keep out of reach of children.

Teneza 20 Tablet, Tenelia 20 Tablet, Teneligliptin 20 mg Tablet (generic), Tenepride 20 Tablet, Tenlimac 20 Tablet